From the G.B. Bietti Foundation I.R.C.C.S., Rome, Italy (Savini, Schiano-Lomoriello); Stein Eye Institute, University of California, Los Angeles, California (Hoffer), St. Mary's Eye Center, Santa Monica, California (Dr. Hoffer); Alcon Italia, S.p.A., Milan, Italy (Carballo); University Eye Clinic, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy (Taroni).
Corresponding author: Giacomo Savini, MD, G.B. Bietti Foundation I.R.C.C.S., Via Livenza, 3—00198 Rome, Italy. Email: [email protected].
The contribution of the G.B. Bietti Foundation I.R.C.C.S. was supported by Fondazione Roma and the Italian Ministry of Health.
Disclosures: G. Savini is a consultant to CSO and has received personal fees from Alcon Laboratories, Inc., Johnson & Johnson, Oculus, and Zeiss. K. J. Hoffer licenses the registered trademark name Hoffer to ensure accurate programming of his formulas to Carl Zeiss Meditec (IOLMasters), Haag-Streit (LenStar/EyeStar), Heidelberg Engineering (Anterion), Oculus (Pentacam AXL), Movu (Argos), Nidek (AL-Scan), Optopol (RENO NX), Tomey (OA-2000), Topcon /VisiaImaging (Aladdin), Ziemer (Galilei G6), and all A-scan biometer manufacturers. L. Carballo is an employee of Alcon Laboratories, Inc. Italia. No other disclosures were reported.
First author:Giacomo Savini, MDI.R.C.C.S.—G.B. Bietti Foundation, Rome, Italy